Jennifer T. Veneris et al. investigated the association between NR3C1 and ovarian serous carcinoma through analysis of whole-genome sequencing and gene expression data from high-grade serous ovarian cancer patients, revealing that elevated expression of the glucocorticoid receptor gene was correlated with poor overall survival in ovarian cancer, regardless of BRCA1 and BRCA2 mutation status (Veneris et al., 2019). The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.